Reviewed,
UniProtKB/Swiss-Prot Q8N8S7 (ENAH_HUMAN)
Last modified
February 9, 2010.
Version 77.
History...
Clusters with 100%,
90%,
50% identity |
Documents (4) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Protein enabled homolog | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 591 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Ena/VASP proteins are actin-associated proteins involved in a range of processes dependent on cytoskeleton remodeling and cell polarity such as axon guidance and lamellipodial and filopodial dynamics in migrating cells. ENAH induces the formation of F-actin rich outgrowths in fibroblasts. Acts synergistically with BAIAP2-alpha and downstream of NTN1 to promote filipodia formation. Required for the actin-based mobility of Listeria monocytogenes By similarity. Ref.7 Ref.20 |
| Subunit structure | Homotetramer By similarity. Interacts with APBB1IP, APBB1, PFN1 and ROBO4. Isoforms, containing the polyproline-rich regions with PPLP motifs, bind the WW domain of APBB1IP. Isoforms, containing the PPSY motif, bind, in vitro, to the WW2 and WW3 domains of NEDD4 and to the WW1 domain of YAP1. Binds the SH3 domain of BAIAP2-alpha but only after the autoinhibitory region of BAIAP2-alpha has been blocked by interaction with CDC42. Interacts, via the EVH1/WH1 domain, with the Pro-rich domains from VCL, ZYX and Listeria monocytogenes actA and with the TES LIM domain. The TES LIM domain and the Pro-rich domains from VCL or ZYX compete for the same binding site. Interaction with ZYX is important for targeting ENAH to focal adhesions and enhances production of actin-rich structures at the apical surface of cells. Interacts, through the Pro-rich region, with the C-terminal SH3 domain of DNMPB. Binds GPHN By similarity. Ref.7 Ref.20 Ref.8 Ref.9 Ref.10 Ref.11 |
| Subcellular location | Cytoplasm. Cytoplasm › cytoskeleton By similarity. Cell projection › lamellipodium By similarity. Cell projection › filopodium By similarity. Cell junction › synapse By similarity. Cell junction › focal adhesion. Note: Targeted to the leading edge of lamellipodia and filopodia by MRL family members. Colocalizes at filopodial tips with a number of other proteins including vinculin and zyxlin. Colocalizes with N-WASP at the leading edge. Colocalizes with GPHN and PFN at synapses By similarity. Ref.20 Ref.12 |
| Tissue specificity | Expressed in myoepithelia of parotid, breast, bronchial glands and sweat glands. Expressed in colon-rectum muscolaris mucosae epithelium, pancreas acinar ductal epithelium, endometrium epithelium, prostate fibromuscolar stroma and placenta vascular media. Overexpressed in a majority of breast cancer cell lines and primary breast tumor lesions. Ref.2 |
| Domain | The EVH2 domain is comprised of 3 regions. Block A is a thymosin-like domain required for G-actin binding. The KLKR motif within this block is essential for the G-actin binding and for actin polymerization. Block B is required for F-actin binding and subcellular location, and Block C for tetramerization. |
| Post-translational modification | NTN1-induced PKA phosphorylation on Ser-265 directly parallels the formation of filopodial protrusions By similarity. Phosphorylated upon DNA damage, probably by ATM or ATR. Ref.13 Ref.14 Ref.15 Ref.16 Ref.17 |
| Sequence similarities | Belongs to the Ena/VASP family. Contains 1 WH1 domain. |
| Sequence caution | The sequence CAH71475.1 differs from that shown. Reason: Erroneous gene model prediction. The sequence CAI22018.1 differs from that shown. Reason: Erroneous gene model prediction. The sequence CAI22020.1 differs from that shown. Reason: Erroneous gene model prediction. |
Ontologies
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q8N8S7-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q8N8S7-2) The sequence of this isoform differs from the canonical sequence as follows: 514-534: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 591 | 591 | Protein enabled homolog | PRO_0000086971 | ||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||
| Domain | 1 – 111 | 111 | WH1 | |||||||||||||||||||||||
| Repeat | 156 – 160 | 5 | 1 | |||||||||||||||||||||||
| Repeat | 161 – 165 | 5 | 2 | |||||||||||||||||||||||
| Repeat | 166 – 170 | 5 | 3 | |||||||||||||||||||||||
| Repeat | 171 – 175 | 5 | 4 | |||||||||||||||||||||||
| Repeat | 176 – 180 | 5 | 5 | |||||||||||||||||||||||
| Repeat | 181 – 185 | 5 | 6 | |||||||||||||||||||||||
| Repeat | 186 – 190 | 5 | 7 | |||||||||||||||||||||||
| Repeat | 191 – 195 | 5 | 8 | |||||||||||||||||||||||
| Repeat | 196 – 200 | 5 | 9 | |||||||||||||||||||||||
| Region | 156 – 200 | 45 | 9 X 5 AA tandem repeats of [LMQ]-E-[QR]-E-[QR] | |||||||||||||||||||||||
| Region | 391 – 588 | 198 | EVH2 | |||||||||||||||||||||||
| Region | 391 – 411 | 21 | EVH2 block A | |||||||||||||||||||||||
| Region | 442 – 459 | 18 | EVH2 block B | |||||||||||||||||||||||
| Region | 554 – 588 | 35 | EVH2 block C | |||||||||||||||||||||||
| Coiled coil | 135 – 265 | 131 | Potential | |||||||||||||||||||||||
| Coiled coil | 557 – 587 | 31 | Potential | |||||||||||||||||||||||
| Motif | 400 – 403 | 4 | KLKR | |||||||||||||||||||||||
| Compositional bias | 310 – 373 | 64 | Pro-rich | |||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||
| Modified residue | 125 | 1 | Phosphoserine Ref.15 Ref.16 Ref.17 | |||||||||||||||||||||||
| Modified residue | 265 | 1 | Phosphoserine; by PKA By similarity | |||||||||||||||||||||||
| Modified residue | 405 | 1 | Phosphoserine Ref.15 | |||||||||||||||||||||||
| Modified residue | 410 | 1 | Phosphothreonine Ref.15 | |||||||||||||||||||||||
| Modified residue | 489 | 1 | Phosphothreonine Ref.14 | |||||||||||||||||||||||
| Modified residue | 502 | 1 | Phosphothreonine Ref.15 | |||||||||||||||||||||||
| Modified residue | 506 | 1 | Phosphoserine Ref.17 | |||||||||||||||||||||||
| Modified residue | 508 | 1 | Phosphoserine Ref.13 Ref.15 Ref.17 | |||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||
| Alternative sequence | 514 – 534 | 21 | Missing in isoform 2. | VSP_010564 | ||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||
| Sequence conflict | 493 | 1 | T → I in AAH95481. Ref.4 | |||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||
| Beta strand | 4 – 17 | 14 | ||||||||||||||||||||||||
| Turn | 18 – 21 | 4 | ||||||||||||||||||||||||
| Beta strand | 22 – 25 | 4 | ||||||||||||||||||||||||
| Helix | 26 – 28 | 3 | ||||||||||||||||||||||||
| Beta strand | 33 – 40 | 8 | ||||||||||||||||||||||||
| Turn | 41 – 44 | 4 | ||||||||||||||||||||||||
| Beta strand | 45 – 52 | 8 | ||||||||||||||||||||||||
| Turn | 53 – 55 | 3 | ||||||||||||||||||||||||
| Beta strand | 58 – 63 | 6 | ||||||||||||||||||||||||
| Beta strand | 74 – 81 | 8 | ||||||||||||||||||||||||
| Beta strand | 86 – 93 | 8 | ||||||||||||||||||||||||
| Helix | 94 – 111 | 18 | ||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Human Mena: cDNA cloning, expression and promoter characterization." Urbanelli L. Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). |
| [2] | "Human Mena protein, a serex-defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T-cell immune response." Di Modugno F., Bronzi G., Scanlan M.J., Del Bello D., Cascioli S., Venturo I., Botti C., Nicotra M.R., Mottolese M., Natali P.G., Santoni A., Jager E., Nistico P. Int. J. Cancer 109:909-918(2004) [PubMed: 15027125] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY. Tissue: Mammary tumor. |
| [3] | "The DNA sequence and biological annotation of human chromosome 1." Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K. Bentley D.R.Nature 441:315-321(2006) [PubMed: 16710414] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 44-591 (ISOFORM 2). Tissue: Placenta and Skin. |
| [5] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 85-591 (ISOFORM 2). Tissue: Teratocarcinoma. |
| [6] | "The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed: 17974005] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 393-591 (ISOFORM 2). Tissue: Testis. |
| [7] | "Cdc42 induces filopodia by promoting the formation of an IRSp53:Mena complex." Krugmann S., Jordens I., Gevaert K., Driessens M., Vandekerckhove J., Hall A. Curr. Biol. 11:1645-1655(2001) [PubMed: 11696321] [Abstract] Cited for: PROTEIN SEQUENCE OF 23-47; 70-81; 123-145; 403-427; 484-499 AND 573-587, FUNCTION, INTERACTION WITH BAIAP2. |
| [8] | "A novel proline-rich motif present in ActA of Listeria monocytogenes and cytoskeletal proteins is the ligand for the EVH1 domain, a protein module present in the Ena/VASP family." Niebuhr K., Ebel F., Frank R., Reinhard M., Domann E., Carl U.D., Walter U., Gertler F.B., Wehland J., Chakraborty T. EMBO J. 16:5433-5444(1997) [PubMed: 9312002] [Abstract] Cited for: INTERACTION WITH VCL; ZYX AND L.MONOCYTOGENES ACTA. |
| [9] | "Characterization of the interaction between zyxin and members of the Ena/vasodilator-stimulated phosphoprotein family of proteins." Drees B., Friederich E., Fradelizi J., Louvard D., Beckerle M.C., Golsteyn R.M. J. Biol. Chem. 275:22503-22511(2000) [PubMed: 10801818] [Abstract] Cited for: INTERACTION WITH ZYX. |
| [10] | "Robo4 is a vascular-specific receptor that inhibits endothelial migration." Park K.W., Morrison C.M., Sorensen L.K., Jones C.A., Rao Y., Chien C.-B., Wu J.Y., Urness L.D., Li D.Y. Dev. Biol. 261:251-267(2003) [PubMed: 12941633] [Abstract] Cited for: INTERACTION WITH ROBO4. |
| [11] | "RIAM, an Ena/VASP and profilin ligand, interacts with Rap1-GTP and mediates Rap1-induced adhesion." Lafuente E.M., van Puijenbroek A.A., Krause M., Carman C.V., Freeman G.J., Berezovskaya A., Constantine E., Springer T.A., Gertler F.B., Boussiotis V.A. Dev. Cell 7:585-595(2004) [PubMed: 15469846] [Abstract] Cited for: INTERACTION WITH APBB1IP. Tissue: T-cell. |
| [12] | "Lamellipodin, an Ena/VASP ligand, is implicated in the regulation of lamellipodial dynamics." Krause M., Leslie J.D., Stewart M., Lafuente E.M., Valderrama F., Jagannathan R., Strasser G.A., Rubinson D.A., Liu H., Way M., Yaffe M.B., Boussiotis V.A., Gertler F.B. Dev. Cell 7:571-583(2004) [PubMed: 15469845] [Abstract] Cited for: SUBCELLULAR LOCATION. |
| [13] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-508, MASS SPECTROMETRY. Tissue: Epithelium. |
| [14] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed: 16964243] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-489, MASS SPECTROMETRY. Tissue: Epithelium. |
| [15] | "Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry." Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A. Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007) [PubMed: 17287340] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125; SER-405; THR-410; THR-502 AND SER-508, MASS SPECTROMETRY. |
| [16] | "ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage." Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J. Science 316:1160-1166(2007) [PubMed: 17525332] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125, MASS SPECTROMETRY. |
| [17] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125; SER-506 AND SER-508, MASS SPECTROMETRY. |
| [18] | Colinge J., Superti-Furga G., Bennett K.L. Submitted (OCT-2008) to UniProtKB Cited for: IDENTIFICATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY. |
| [19] | "Structural basis for polyproline recognition by the FE65 WW domain." Meiyappan M., Birrane G., Ladias J.A.A. J. Mol. Biol. 372:970-980(2007) [PubMed: 17686488] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.33 ANGSTROMS) OF 347-356 IN COMPLEX WITH APBB1. |
| [20] | "Tes, a specific Mena interacting partner, breaks the rules for EVH1 binding." Boeda B., Briggs D.C., Higgins T., Garvalov B.K., Fadden A.J., McDonald N.Q., Way M. Mol. Cell 28:1071-1082(2007) [PubMed: 18158903] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 1-113 IN COMPLEX WITH TES, INTERACTION WITH ZYX, FUNCTION, SUBCELLULAR LOCATION. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AY345143 mRNA. Translation: AAR04685.1. AF519769 mRNA. Translation: AAQ08487.1. AL591380, AC092811, AL356216 Genomic DNA. Translation: CAH71475.1. Sequence problems. AL591380, AC092811, AL356216 Genomic DNA. Translation: CAH71476.1. AL356216, AC092811 Genomic DNA. Translation: CAI22018.1. Sequence problems. AL356216, AL591380, AC092811 Genomic DNA. Translation: CAI22019.1. AL356216, AL591380, AC092811 Genomic DNA. Translation: CAI22020.1. Sequence problems. BC065238 mRNA. Translation: AAH65238.1. BC095481 mRNA. Translation: AAH95481.1. AK001635 mRNA. Translation: BAA91799.1. Different initiation. AK096246 mRNA. Translation: BAC04736.1. Different initiation. AL133059 mRNA. Translation: CAB61384.1. | ||||||||||||||||||
| IPI | IPI00374054. IPI00411623. | ||||||||||||||||||
| PIR | T42661. | ||||||||||||||||||
| RefSeq | NP_001008493.1. NP_060682.2. | ||||||||||||||||||
| UniGene | Hs.497893 | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||
| SMR | Q8N8S7. Positions 366-405, 550-588. | ||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| STRING | Q8N8S7. | ||||||||||||||||||
PTM databases | |||||||||||||||||||
| PhosphoSite | Q8N8S7. | ||||||||||||||||||
Proteomic databases | |||||||||||||||||||
| PRIDE | Q8N8S7. | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENST00000366844; ENSP00000355809; ENSG00000154380; Homo sapiens. [Genome view] | ||||||||||||||||||
| GeneID | 55740. | ||||||||||||||||||
| KEGG | hsa:55740. | ||||||||||||||||||
| NMPDR | fig|9606.3.peg.3149. | ||||||||||||||||||
| UCSC | uc001hpc.1. human. uc001hpd.1. human. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| CTD | 55740. | ||||||||||||||||||
| GeneCards | GC01M223741. | ||||||||||||||||||
| H-InvDB | HIX0001634. | ||||||||||||||||||
| HGNC | HGNC:18271. ENAH. | ||||||||||||||||||
| MIM | 609061. gene. | ||||||||||||||||||
| PharmGKB | PA38517. | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| eggNOG | prNOG15563. | ||||||||||||||||||
| HOVERGEN | Q8N8S7. | ||||||||||||||||||
| PhylomeDB | Q8N8S7. | ||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||
| Reactome | REACT_18266. Axon guidance. REACT_6900. Signaling in Immune system. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| ArrayExpress | Q8N8S7. | ||||||||||||||||||
| Bgee | Q8N8S7. | ||||||||||||||||||
| CleanEx | HS_ENAH. | ||||||||||||||||||
| Genevestigator | Q8N8S7. | ||||||||||||||||||
| GermOnline | ENSG00000154380. Homo sapiens. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| InterPro | IPR000697. EVH1. IPR011993. PH_type. IPR000156. RanBP. IPR014885. VASP_tetra. [Graphical view] | ||||||||||||||||||
| Gene3D | G3DSA:2.30.29.30. PH_type. 1 hit. | ||||||||||||||||||
| Pfam | PF08776. VASP_tetra. 1 hit. PF00568. WH1. 1 hit. [Graphical view] | ||||||||||||||||||
| SMART | SM00160. RanBD. 1 hit. SM00461. WH1. 1 hit. [Graphical view] | ||||||||||||||||||
| PROSITE | PS50229. WH1. 1 hit. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Other Resources | |||||||||||||||||||
| NextBio | 60693. | ||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
Entry information
| Entry name | ENAH_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q8N8S7 Secondary accession number(s): Q502W5 Q9UFB8 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 1 Human chromosome 1: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


